Literature DB >> 9786457

Cytokines and embryo implantation.

C Simón1, C Moreno, J Remohí, A Pellicer.   

Abstract

The implantation process is currently considered the most relevant limiting factor for successful pregnancy. It is evident that molecular interactions at the embryo-maternal interface at the time of implantation are crucial in order to understand the mechanisms of embryonic implantation. The principal aim of this study is to demonstrate the existence of specific communication pathways between the human embryo and endometrium. The molecular interactions appears to be initiated by the endometrium in the presence of an implanting blastocyst and is mediated through embryonic cytokines (specifically the IL-1 system) and the target is the endometrial epithelial beta3 integrin subunit. If the role of beta3 is accepted as a marker of uterine receptivity these results may indicate that the normal hormonally regulated human endometrium could be the trigger for molecular events preparing the blastocyst to communicate effectively and regulate endometrial adhesion molecules in order to implant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786457     DOI: 10.1016/s0165-0378(98)00017-5

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  27 in total

1.  An in vitro model for the study of human implantation.

Authors:  Jennie C Holmberg; Severina Haddad; Vera Wünsche; Yang Yang; Paulomi B Aldo; Yulia Gnainsky; Irit Granot; Nava Dekel; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-12-12       Impact factor: 3.886

2.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

Review 3.  Genetics and Epigenetics of Infertility and Treatments on Outcomes.

Authors:  Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

4.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.

Authors:  A Akoum; C Jolicoeur; A Kharfi; M Aubé
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Death effector domain-containing protein (DEDD) is required for uterine decidualization during early pregnancy in mice.

Authors:  Mayumi Mori; Miwako Kitazume; Rui Ose; Jun Kurokawa; Kaori Koga; Yutaka Osuga; Satoko Arai; Toru Miyazaki
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

6.  Rapamycin Corrects T Regulatory Cell Depletion and Improves Embryo Implantation and Live Birth Rates in a Murine Model.

Authors:  Greene Donald Royster; Justine C Harris; Amanda Nelson; Yessenia Castro; R Patrick Weitzel; John Tisdale; Ryan J Heitmann; Alan H DeCherney; Erin F Wolff
Journal:  Reprod Sci       Date:  2019-02-19       Impact factor: 3.060

7.  Gene profiling the window of implantation: Microarray analyses from human and rodent models.

Authors:  Jennifer L Herington; Yan Guo; Jeff Reese; Bibhash C Paria
Journal:  J Reprod Health Med       Date:  2016-12-09

8.  A subset of human uterine endometrial macrophages is alternatively activated.

Authors:  Amy L Jensen; Jane Collins; Emilie P Shipman; Charles R Wira; Paul M Guyre; Patricia A Pioli
Journal:  Am J Reprod Immunol       Date:  2012-08-06       Impact factor: 3.886

9.  STAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantation.

Authors:  Sandeep Pawar; Elina Starosvetsky; Grant D Orvis; Richard R Behringer; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2013-10-07

10.  Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients.

Authors:  D Haouzi; S Assou; K Mahmoud; S Tondeur; T Rème; B Hedon; J De Vos; S Hamamah
Journal:  Hum Reprod       Date:  2009-02-26       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.